Fever of unknown origin in the HIV-infected patient: New scenario for an old problem

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 4, 1997, Pages 327-336

  Mayo, Jose ^a   Collazos, Julio ^a   Martinez, Eduardo ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ARTICLE; BIOCHEMISTRY; BONE MARROW BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEMATOLOGY; HISTORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; OPPORTUNISTIC INFECTION; PALLIATIVE THERAPY; PHYSICAL EXAMINATION; PYREXIA IDIOPATHICA; RADIODIAGNOSIS; SCINTISCANNING; SERODIAGNOSIS; TERMINAL DISEASE; TUBERCULOSIS;

EID: 0030656417     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709011826     Document Type: Article

References (120)

1. Durack DT, Street AC. Fever of unknown origin: reexamined and redefined. Curr Clin Top Infect Dis 11: 35-51, 1991.
2. Kazanjian PH. Fever of unknown origin: review of 86 patients treated in community hospitals. Clin Infect Dis 15: 968-73, 1992.
3. Ponce-de-León-Rosales S, Molina-Gamboa J, Rivera-Morales I. The changing spectrum of fever of unknown origin in Mexico. Clin Infect Dis 19: 353, 1994.
4. Hulman SJ, Modesitt S, Klockner R, Bennett D, Fleming D. Causes of hospitalizations following AIDS diagnosis in a population-based cohort (Abstract No. W.B.P. 273). In: Program and Abstracts of the 5th International Conference on AIDS. Montreal. Ottawa: International Development Research Centre, 397, 1989.
5. Bissuel F, Leport C, Perronne C, Longuet P, Vildé JL. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med 236: 529-35, 1994.
6. Carbonell Biot C, Ena Muñoz J, Pasquau Liano F, Badía Ferando P, Ortiz de Salazar Martin A, Vilar Zanón A. Fiebre de origen desconocido en pacientes infectados por el virus de la inmunodeficiencia humana. Rev Clin Esp 196: 4-8, 1996.
7. Genné D, Chave JP, Glauser MP. Fièvre d'origine indéterminée dans un collectif de patients HIV positifs. Schweiz Med Wochenschr 122: 1797-802, 1992.
8. Lozano F, Viciana P, Gómez-Mateos JM, Cañas E, Pujol E. Fever of unknown etiology in HIV-infected patients (Abstract No. 803). In: Program and Abstracts of the 6th European Congress of Clinical Microbiology and Infectious Diseases. Seville: European Society of Clinical Microbiology and Infectious Diseases, 204, 1993.
9. Miralles P, Moreno S, Pérez-Tascón M, Cosín J, Díaz MD, Bouza E. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis 20: 872-5, 1995.
10. Knobel H, Supervía A, Salvadó M, Gimeno JL, López-Colomes JL, Saballs P, Drobnic L, Díez A. Fiebre de origen desconocido en pacientes con infección por el virus de la inmunodeficiencia humana. Estudio de 100 casos. Rev Clin Esp 196: 349-53, 1996.
11. Foley NM, Hingorani AD, Pitkin AD, Miller RF. Pyrexia of undetermined origin in patients with human immunodeficiency virus infection (Abstract No. PO-B06-1107). In: Program and Abstracts of the 9th International Conference on AIDS. Berlin: Institute for Clinical and Experimental Virology of the Free University of Berlin, 320, 1993.
12. Iribarren JA, Oyarbide I, Arrizabalaga J, Rodríguez F, von Wichmann MA, Idígoras P, Mentxaka B. FUO in HIV patients: a study of 83 episodes (Abstract No. PA 0127). In: Program and Abstracts of the 10th International Conference on AIDS. Yokohama: Organizing Committee for the 10th International Conference on AIDS 127, 1994.
13. Pierone G, Lin J, Masci J, Nicholas P. Fever of unknown origin in AIDS (Abstract No. Th. B.540). In: Program and Abstracts of the 6th International Conference on AIDS. San Francisco: University of California San Francisco, 257, 1990.
14. Lozano F, Pujol E, Torres-Cisneros J, Bascuñana A, Cañas E, García-Ordóñez MA, Hernández-Quero J, Vergara A, Márquez M, Díez F, Torres M, Pasquau J, Hernández-Burruezo JJ, Suárez I. Fever of unknown origin in HIV-infected patients: a multicentric-prospective study of 116 cases (Abstract No. PB0803). In: Program and Abstracts of the 10th International Conference on AIDS. Yokohama: Organizing Committee for the 10th International Conference on AIDS 197, 1994.
15. Quist J, Hill AR. Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis, and bacterial pneumonia. Chest 108: 415-8, 1995.
16. Albrecht H, Skörde J, Arasteh K, Heise W, Stellbrink HJ, Grosse G, L'Age M. Disseminated toxoplasmosis in AIDS patients: report of 16 cases. Scand J Infect Dis 27: 71-4, 1995.
17. Chin DP, Reingold AL, Horsburgh CR Jr, Yajko DM, Hadley WK, Elkin EP, Stone EN, Simon EM, Gonzalez PC, Ostrof SM, Jacobson MA, Hopewell PC. Predicting Mycobacterium avium complex bacteremia in patients infected with human immunodeficiency virus: a prospectively validated model. Clin Infect Dis 19: 668-74, 1994.
18. Hoepelman AIM, van Buren M, van den Broek J, Borleffs JCC. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS 6: 179-84, 1992.
19. Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 155: 1641-8, 1995.
20. Zurlo JJ, Feuerstein IM, Lebovics R, Lane HC. Sinusitis in HIV-1 infection. Am J Med 93: 157-62, 1992.
21. Shriner KA, Mathisen GE, Goetz MB. Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls. Clin Infect Dis 15: 601-5, 1992.
22. Hanson DL, Chu SY, Farizo KM, Ward JW, and the Adult and Adolescent Spectrum of HIV Disease Project Group. Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. Arch Intern Med 155: 1537-42, 1995.
23. Navarro V, Nieto A, Bernacer B, Borrás R, Ferrer C. Neumonía por P. carinii en el SIDA y fiebre prolongada. An Med Intern (Madrid) 9: 87-90, 1992.
24. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann Intern Med 104: 234-40, 1986.
25. Koehler JE, Tappero JW. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus. Clin Infect Dis 17: 612-24, 1993.
26. Wheat LJ, Connolly-Stringfield PA, Baker RL, Curfman MF, Eads ME, Israel KS, Norris SA, Webb DH, Zeckel ML. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 69: 361-74, 1990.
27. Karcher DS. Clinically unsuspected Hodgkin disease presenting initially in the bone marrow of patients infected with the human immunodeficiency virus. Cancer 71: 1235-8, 1993.
28. McKenzie R, Travis WD, Dolan SA, Pittaluga S, Feuerstein IM, Shelhamer J, Yarchoan R, Masur H. The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases. Medicine (Baltimore) 70: 326-43, 1991.
29. Monforte AA, Vago L, Lazzarin A, Boldorini R, Bini T, Guzzetti S, Antinori S, Moroni M, Costanzi G. AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. AIDS 6: 1159-64, 1992.
30. Centro Nacional de Epidemiología. Vigilancia del SIDA en España. Informe trimestral No. 3, 30 septiembre 1995.
31. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe. Quarterly report No. 47, 30 September 1995.
32. American Thoracic Society. Control of tuberculosis in the United States. Am Rev Respir Dis 146: 1623-33, 1992.
33. Benson CA, Ellner JJ. Mycobacterium avium complex infection and AIDS: Advances in theory and practice. Clin Infect Dis 17: 7-20, 1993.
34. Sepkowitz KA, Telzak EE, Carrow M, Armstrong D. Fever among outpatients with advanced human immunodeficiency virus infection. Arch Intern Med 153: 1909-12, 1993.
35. Berenguer J, Moreno S, Cercenado E, Bernaldo de Quirós JCL, García de la Fuente A, Bouza E. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med 111: 129-32, 1989.
36. Medrano FJ, Hernández-Quero J, Jiménez E, Pineda JA, Rivero A, Sánchez-Quijano A, Vélez ID, Viciana P, Castillo R, Reyes MJ, Carvajal F, Leal F, Lissen E. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS 6: 1499-503, 1992.
37. Engels E, Marks PW, Kazanjian P. Usefulness of bone marrow examination in the evaluation of unexplained fevers in patients infected with human immunodeficiency virus. Clin Infect Dis 21: 427-8, 1995.
38. Morais JC, Pilotto J, Veloso V, Spector N, Castro D, Sobreira A. Bone marrow biopsy in HIV+ patients in Rio de Janeiro (Brazil): a histological, clinical, hematological and microbiological study of 68 cases (Abstract No. POB 3226). In: Program and Abstracts of the 8th International Conference on AIDS. Amsterdam: Harvard University & Dutch Foundation AIDS Conference 1992, B124, 1992.
39. Soriano V, Valencia E, Alba A, Laguna F, Moreno V, Alberdi JC, García-Samaniego J, González-Lahoz J. Cambios en el espectro de enfermedades en pacientes hospitalizados con infeccion por VIH. Med Clin (Barc) 101: 736-40, 1993.
40. Selik RM, Chu SY, Ward JW. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med 123: 933-6, 1995.
41. Saah AJ, Hoover DR, Peng Y, Phair JP, Visscher B, Kingsley LA, Schrager LK. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study. JAMA 273: 1197-202, 1995.
42. Powderly WG, Finkelstein DM, Feinberg J, Frame P, He W, van der Horst C, Koletar SL, Eyster ME, Carey J, Waskin H, Hooton TM, Hyslop N, Spector SA, Bozzette SA. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 332: 700-5, 1995.
43. Quagliarello VJ, Viscoli C, Horwitz RI. Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients. Lancet 345: 548-52, 1995.
44. Moreno S, Baraia-Etxaburu J, Bouza E, Parras F, Pérez-Tascón M, Miralles P, Vicente T, Alberdi JC, Cosín J, López-Gay D. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 119: 194-8, 1993.
45. Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, Miró JM, Mallolas J, Zamora L, González J, Soriano E. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 7: 1345-9, 1993.
46. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 342: 268-72, 1993.
47. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 268: 504-9, 1992.
48. Jones BE, Otaya M, Antoniskis D, Sian S, Wang F, Mercado A, Davidson PT, Barnes PF. A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection. Am J Respir Crit Care Med 150: 1499-502, 1994.
49. Kassim S, Sassan-Morokro M, Ackah A, Abouya LY, Digbeu H, Yesso G, Coulibaly IM, Coulibaly D, Whitaker PJ, Doorly R, Vetter KM, Brattegaard K, Gnaore E, Greenberg AE, Wiktor SZ, De Cock KM. Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa. AIDS 5: 1185-91, 1995.
50. Perriëns JH, St. Louis ME, Mukadi YB, Brown C, Prignot J, Pouthier F, Portaels F, Willame JC, Mandala JK, Kaboto M, Ryder RW, Roscigno G, Piot P. Pulmonary tuberculosis in HIV-infected patients in Zaire: a controlled trial of treatment for either 6 or 12 months. N Engl J Med 332: 779-84, 1995.
51. Perronne C, Ghoubontni A, Leport C, Salmon-Céron D, Bricaire F, Vildé JL. Should pulmonary tuberculosis be an AIDS defining diagnosis in patients infected with HIV? Tubercle Lung Dis 73: 39-44, 1992.
52. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 324: 289-94, 1991.
53. Nightingale SD, Cameron DW, Gordin FM, Sullam PM, Cohn DL, Chaisson RE, Eron LJ, Sparti PD, Bihari B, Kaufman DL, Stern JJ, Pearce DD, Weinberg WG, LaMarca A, Siegal FP. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 329: 828-33, 1993.
54. Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M, Wormser GP, Jablonowski H, Jemsek J, Cynamon M, Yangco BG, Notario G, Craft JC. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 335: 384-91, 1996.
55. Havlir DW, Dubé MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Lavelle JP, White AC Jr, Witt MD, Bozzette SA, McCutchan JA. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N Engl J Med 335: 392-8, 1996.
56. Renold C, Sugar A, Chave JP, Perrin L, Delavelle J, Pizzolato G, Burkhard P, Gabriel V, Hirschel B. Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore) 71: 224-39, 1992.
57. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 15: 211-22, 1992.
58. Monforte AA, Mainini F, Vago L, Magni C, Mussico M, Antinori S, Bini T, Moroni M. Factors associated with increased risk of acquiring cytomegalovirus disease in AIDS patients. J Infect Dis 168: 1071-2, 1993.
59. Chou S. Newer methods for diagnosis of cytomegalovirus infection. Rev Infect Dis 12 (Suppl 7 P): S727-36, 1990.
60. Fish DG, Ampel NM, Galgiani JM, Dols CL, Kelly PC, Johnson CH, Pappagianis D, Edwards JE, Wasserman RB, Clark RJ, Antoniskis D, Larsen RA, Englender SJ, Petersen EA. Coccidioidomycosis during human immunodeficiency virus infection: a review of 77 patients. Medicine (Baltimore) 69: 384-91, 1990.
61. Stevens DA. Coccidioidomycosis. N Engl J Med 332: 1077-82, 1995.
62. Gerna G, Parea M, Percivalle E, Zipeto D, Silini E, Barbarini G, Milanesi G. Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection. AIDS 4: 1027-31, 1990.
63. Dodt KK, Jacobsen PH, Hofman B, Meyer C, Kolmos HJ, Skinhoj P, Norrild B, Mathiesen L. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS 110: F21-8, 1997.
64. Martínez Lacasa JT, Podzamczer D, Rufí G, Bolao F, Pérez JL, Gudiol F. Enfermedad por citomegalovirus en pacientes afectados del síndrome de inmunodeficiencia adquirida: a propósito de 63 episodios. Med Clin (Barc) 100: 41-5, 1993.
65. Barber TW, Craven DE, McCabe WR. Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection: a report of 9 cases and a review of the literature. Medicine (Baltimore) 69: 375-83, 1990.
66. Shafer RW, Goldberg R, Sierra M, Glatt AE. Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in an area endemic for AIDS. Am Rev Respir Dis 140: 1611-3, 1989.
67. Ellner JJ, Goldberger MJ, Parenti DM. Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J Infect Dis 163: 1326-35, 1991.
68. Wallace JM, Hannah JB. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome: a clinico-pathologic study. Chest 93: 926-32, 1988.
69. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 321: 794-9, 1989.
70. Friedmann PD, Samore MH, Kraemer KL, Calkins DR. Clinical correlates of secondary meningitis in HIV-infected adults. Arch Intern Med 155: 2231-7, 1995.
71. Torroba Alvarez L, Fortún Abete J, Buzón Rueda L, Moreno Caparrós A. Fiebre de origen desconocido y antigeno criptocócico. Med Clin (Barc) 91: 514, 1988.
72. Huskinson J, Stepick-Biek P, Remington JS. Detection of antigens in urine during acute toxoplasmosis. J Clin Microbiol 27: 1099-101, 1989.
73. Asensi V, Carton JA, Maradona JA, Oña M, Arribas JM. Clinical value of blood cultures for detection of Toxoplasma gondii in human immunodeficiency virus-seropositive patients with and without cerebral lesions on computerized tomography. Clin Infect Dis 17: 511-2, 1993.
74. Rabaud C, May T, Amiel C, Katlama C, Leport C, Ambroise-Thomas P, Canton P. Extracerebral toxoplasmosis in patients infected with HIV: A French national survey. Medicine (Baltimore) 73: 306-14, 1994.
75. Tirard V, Niel G, Rosenheim M, Katlama C, Ciceron L, Ogunkolade W, Danis M, Gentilini M. Diagnosis of toxoplasmosis in patients with AIDS by isolation of the parasite from the blood. N Engl J Med 324: 634, 1991.
76. Medrano FJ, Jiménez-Mejías E, Calderón E, Regordán C, Leal M. An easy and quick method for the diagnosis of visceral leishmaniasis in HIV-1- infected individuals. AIDS 7: 1399, 1993.
77. McKinsey DS, Gupta MR, Riddler SA, Driks MR, Smith DL, Kurtin PJ. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 111: 655-9, 1989.
78. Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 324: 1644-50, 1991.
79. Shafer RW, Kim DS, Weiss JP, Quale JM. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 70: 384-97, 1991.
80. Moreno S, Baraia-Etxaburu J, Miralles P, Berenguer J, Cosín J, Bernaldo de Quirós JCL. Tuberculin reaction size en patients infected with HIV. AIDS 9: 1289-90, 1995.
81. Radin R. Intraabdominal Mycobacterium tuberculosis versus Mycobacterium avium-intracellulare infections in patients with AIDS: distinction based on CT findings. Am J Roentgenol 156: 487-91, 1991.
82. Federle MP. A radiologist looks at AIDS: imaging evaluation based on symptom complexes. Radiology 166: 553-62, 1988.
83. Lupatkin H, Bräu N, Flomenberg P, Simberkoff MS. Tuberculous abscesses in patients with AIDS. Clin Infect Dis 14: 1040-4, 1992.
84. Khalil T, Uzoaru I, Nadimpalli V, Wurtz R. Splenic tuberculous abscess in patients positive for human immunodeficiency virus: report of two cases and review. Clin Infect Dis 14: 1265-6, 1992.
85. Jaber B, Gleckman R. Tuberculous pancreatic abscess as an initial AIDS-defining disorder in a patient infected with the human immunodeficiency virus: case report and review. Clin Infect Dis 20: 890-4, 1995.
86. Fee MJ, Oo MM, Gabayan AE, Radin DR, Barnes PF. Abdominal tuberculosis in patients infected with the human immunodeficiency virus. Clin Infect Dis 20: 938-44, 1995.
87. Weissman AF, Fig LM, Sisson J, Seow L, Shapiro B. The role of scintigraphy in the evaluation of fever of unknown origin. Am Fam Physician 50: 1717-27, 1994.
88. Santín M, Podzamczer D, Ricart I, Mascaró J, Ramón JM, Dominguez A, Rufí G, Gudiol F. Utility of the gallium-67 citrate scan for the early diagnosis of tuberculosis in patients infected with the human immunodeficiency virus. Clin Infect Dis 20: 652-6, 1995.
89. Fineman DS, Palestro CJ, Kim CK, Needle LB, Vallabhajosula S, Solomon RW, Goldsmith SJ. Detection of abnormalities in febrile AIDS patients with In-111-labeled leukocyte and Ga-67 scintigraphy. Radiology 170: 677-80, 1989.
90. Buscombe JR, Oyen WJ, Corstens FH, Ell PJ, Miller RF. Localization of infection in HIV antibody-positive patients with fever: comparison of the efficacy of Ga-67 citrate and radiolabeled human IgG. Clin Nucl Med 20: 334-9, 1995.
91. Comer GM, Mukherjee S, Scholes JV, Holness LG, Clain DJ. Liver biopsies in the acquired immune deficiency syndrome: influence of endemic disease and drug abuse. Am J Gastoenterol 84: 1525-31, 1989.
92. Bertrán X, Planas R, Mate JL. Alteraciones hepáticas en los pacientes con infección aislada por el virus de la inmunodeficiencia humana y con SIDA. Med Clin (Barc) 99: 168-71, 1992.
93. Cappell MS, Schwartz MS, Biempica L. Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus. Am J Med 88: 123-30, 1990.
94. Cavicchi M, Pialoux G, Carnot F, Offredo C, Romana C, Deslandes P, Dupont B, Berthelot P, Pol S. Value of liver biopsy for the rapid diagnosis of infection in human immunodeficiency virus-infected patients who have unexplained fever and elevated serum levels of alkaline phosphatase or gamma-glutamyl transferase. Clin Infect Dis 20: 606-10, 1995.
95. Escartín Muñoz-Ortiz P, López G-Asenjo JA, García González C, Roca Arbones V, Taxonera Samso C, Pieltain Alvarez-Arenas R, Diaz Rubio M. El espectro de la hepatopatia en la infección por el virus de la inmunodeficiencia humana: estu-dio de 50 biopsias hepáticas. Med Clin (Barc) 97: 201-5, 1991.
96. Kahn SA, Saltzman BR, Klein RS, Mahadevia PS, Friedland GH, Bradt LJ. Hepatic disorders in the acquired immune deficiency syndrome: a clinical and pathological study. Am J Gastroenterol 81: 1145-8, 1986.
97. Lebovics E, Thung SN, Schaffner F, Radensky PW. The liver in the acquired immunodeficiency syndrome: a clinical and histologie study. Hepatology 5: 293-8, 1985.
98. Lima BD, Jurado E, Pinho P, Moreira P, Paiva D. Critical analysis of hepatic biopsies in AIDS (Abstract No. PB0951). In: Program and Abstracts of the 10th International Conference on AIDS. Yokohama: Organizing Committee for the 10th International Conference on AIDS, 234, 1994.
99. Martínez P, González de Etxabarri S, Muñoz J, Santamaría JM, Ereño C, Miguel F. Enfermedad hepática asociada a la infección por el virus de la inmunodeficiencia humana: estudio anatomo-clínico. Rev Esp Enferm Apar Dig 85: 331-7, 1994.
100. Mendonça JS, Hanna G, Yamaguti DC. Liver biopsy evaluation in HIV-positive inpatients (Abstract No. POB3221). In: Program and Abstracts of the 8th International Conference on AIDS. Amsterdam: Harvard University & Dutch Foundation AIDS Conference 1992, B123, 1992.
101. Oehler R, Loos U, Ferber J, Fischer HP. Diagnostic value of liver biopsy in HIV patients with unexplained fever (Abstract No. PoB 3722). In: Program and Abstracts of the 8th International Conference on AIDS. Amsterdam: Harvard University & Dutch Foundation AIDS Conference 1992, B211, 1992.
102. Prego V, Glatt AE, Roy V, Thelmo W, Dincsoy H, Raufman JP. Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients. Arch Intern Med 150: 333-6, 1990.
103. Puoti M, Gregis GP, Spinetti A, Fracassetti O, Rossi S, Favret M, Bonetti M, Matricardi L, Carosi G. Comparative yield of blood culture and liver biopsy in the diagnosis of mycobacterial infection in AIDS patients with fever of unknown origin (Abstract No. P358). In: Program and Abstracts of the 4th European Conference on Clinical Aspects and Treatment of HIV Infection. Milan: European AIDS Clinical Society, 248, 1994.
104. Rogeaux O, Priqueler L, Hoang C, Cadranel JF, Opolon P, Gentilini M. Diagnostic usefulness of liver biopsy for unexplained fever in HIV patients (Abstract No. PO-B19-1867). In: Program and Abstracts of the 9th International Conference on AIDS. Berlin: Institute for Clinical and Experimental Virology of the Free University of Berlin, 320, 1993.
105. Santos Gil I, Jaras Hernández MJ, Sánchez Molini P, García Monzón C, Del Arco Galán C. Afección hepática en pacientes con infección por el virus de la inmunodeficiencia humana: estudio de cien biopsias. Rev Clin Esp 193: 115-8, 1993.
106. Schneiderman DJ, Arenson DM, Cello JP, Margaretten W, Weber TE. Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS). Hepatology 7: 925-30, 1987.
107. Bonacini M. Hepatobiliary complications in patients with human immunodeficiency virus infection. Am J Med 92: 404-11, 1992.
108. Catalán S, Díaz-López B, López-Cubero L, Alonso-Sanz M, Dronda F, González-López A. Bone marrow findings in HIV-infected patients: analysis of 116 cases in Spanish inmates (Abstract No. 166). In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco. Washington: American Society for Microbiology, 216, 1995.
109. Ciaudo M, Doco-Lecompte T, Guettier C, d'Agay MF, David F, Rioual N, Buu-Hoi A, Molina JM, Kazatchkine M, Modai J. Revisited indications for bone marrow examinations in HIV-infected patients. Eur J Haematol 53: 168-74, 1994.
110. Fumagalli L, Danise A, Castagna A, Faravelli A, Scarpellini P, Germagnoli L, Cicchero P, Lazzarin A. Bone marrow aspiration and biopsy: role in the diagnosis of opportunistic infections in HIV-positive patients (Abstract No. P301). In: Program and Abstracts of the 4th European Conference on Clinical Aspects and Treatment of HIV Infection. Milan: European AIDS Clinical Society, 209, 1994.
111. López MP, Romeu J, Vela MD, Manterola JM, Raventós A, Cirera G, Clotet B. Diagnostic yield of bone marrow examination in AIDS patients with prolonged fever (Abstract No. P303). In: Program and Abstracts of the 4th European Conference on Clinical Aspects and Treatment of HIV infection. Milan: European AIDS Clinical Society, 210, 1994.
112. Martínez P, Soriano V, Ortega A, De la Vega E, March J, Laguna F, Moreno V, Valencia E, Díaz F, González-Lahoz J. Usefulness of bone marrow aspirate examination in HIV+ patients in Spain (Abstract No. P302). In: Program and Abstracts of the 4th European Conference on Clinical Aspects and Treatment of HIV Infection. Milan: European AIDS Clinical Society, 209, 1994.
113. Northfelt DW, Mayer A, Kaplan LD, Abrams DI, Hadley WK, Yajko DM, Herndier BG. The usefulness of diagnostic bone marrow examinations in patients with human immunodefiency virus (HIV) infection. J Acquir Immune Defic Syndr 4: 659-66, 1991
114. Nuñez A, Benito N, Górgolas M, Esteban MJ, Guerrero F. Bone marrow biopsy in the diagnosis of fever of unknown origin in patients with AIDS (Abstract No. 165). In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco. Washington: American Society for Microbiology, 216, 1995.
115. Barreto JA, Palaci M, Ferrazoli L, Martins MC, Suleiman J, Lorenco R, Ferreira OC Jr, Riley LW, Johnson WD Jr, Galvao PA. Isolation of Mycobacterium avium complex from bone marrow aspirates of AIDS patients in Brazil. J Infect Dis 168: 777-9, 1993.
116. Pilkington R, Leonard N, O'Dowd J, O'Briain DS, Mulcahy F. Bone marrow in HIV infection: a useful clinical test? (Abstract No. WS-B22-1). In: Program and Abstracts of the 9th International Conference on AIDS. Berlin: Institute for Clinical and Experimental Virology of the Free University of Berlin, 65, 1993.
117. Duggan MJ, Weisenburger DD, Sun NCJ, Purtilo DT. Bone marrow findings in immunodeficiency syndromes. Hematol Oncol Clin North Am 2: 637-56, 1988.
118. Hollander H, MacGuire D, Burack JH. Diagnostic lumbar puncture in HIV-infected patients: analysis of 138 cases. Am J Med 96: 223-8, 1994.
119. Anglaret X, Saba J, Perronne C, Lacasim F, Longuet P, Leport C, Vilde JL. Empiric antituberculosis treatment: Benefits for earlier diagnosis and treatment of tuberculosis. Tubercle Lung Dis 75: 334-40, 1994.
120. Steven N, Pithie A, Wood M, Innes J. Corticosteroid therapy for AIDS patients with Mycobacterium avium-intracellulare infection. AIDS 8: 136-8, 1994.